Safety of multicomponent meningococcal group B vaccine
The Lancet Child & Adolescent Health in conversation with - Un podcast de The Lancet Group
Catégories:
Philip Bryan joins The Lancet Child & Adolescent Health to discuss the safety of multicomponent meningococcal group B vaccine (4CMenB) in the UK’s infant immunisation programme. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://www.linkedin.com/company/lanchi/ https://youtube.com/thelancettv
